E. Rand Sutherland, M.D.

E. Rand Sutherland, M.D.

Chief Executive OfficeratUpstream Bio· In proxies 2024–2025

Pay in FY2025-53% from the year before · Upstream Bio stock +65.1% the same year

E. Rand Sutherland, M.D. was paid $4.3M in FY2025 (Dec), down 53%. Upstream Bio stock rose 65.1% that year.

Pay$100 in the stock at the end of FY24 → $165
Pay is from the Summary Compensation Table of each Upstream Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Upstream BioPublic company · 2 yr
    • Chief Executive Officer2024 – Present · 2 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?